Dr. Sajid Z. Malik

Dr. Sunil A. Sheth, MD is a board-certified Vascular Neurologist specializing in in endovascular treatments for cerebral and spinal vascular diseases. He has expertise in the treatment of ischemic and hemorrhagic stroke, brain aneurysms, arteriovenous malformations, fistulas, as well as facial and spinal vascular malformations. Dr. Sheth is originally from Houston, TX and attended Harvard Medical School where he graduated magna cum laude. He completed his residency in Neurology at the University of California, San Francisco where he served as the chief resident, and fellowships in Vascular Neurology and Interventional Neuroradiology at the University of California, Los Angeles. Dr. Sheth is currently an Assistant Professor of Neurology at UT Health McGovern Medical School. Dr. Sheth has co-authored many studies, which have been published in Cell, Nature Biotechnology, PlosONE, and the Journal of NeuroInterventional Surgery. For his research work he has been awarded grants from the American Heart Association (AHA), Society for NeuroInterventional Surgery Foundation, and National Institutes of Health. He has also received numerous honors and awards and lectured across the country on the management of ischemic stroke and cerebrovascular disease. Dr. Sheth’s clinical and research interests include endovascular treatments for ischemic stroke, neuroimaging, traumatic brain injury, and development of novel endovascular devices. Dr. Sheth is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Stroke, Brain Aneurysm, Subarachnoid Hemorrhage, Thrombectomy, and Stent Placement. Dr. Sheth is currently accepting new patients.

Dr. Sigmund Hsu is fellowship trained and certified by the American Board of Psychiatry and Neurology, with extensive experience in the evaluation and treatment of neurological disorders in cancer patients. He specializes in primary brain tumors as well as brain and spinal cord metastases, cancer neurology and the treatment of chemotherapy neurotoxicity. Dr. Hsu earned both his undergraduate and medical degrees from Brown University in Providence, Rhode Island. He completed his medical internship at the Hospital of St. Raphael at Yale University in New Haven, Connecticut, where he was awarded medical intern of the year in 1996. After his residency at Weill Cornell Medical Center in New York, with Fred Plum, MD, and Jerome Posner, MD, Dr. Hsu completed his fellowship training in neuro-oncology at The University of Texas MD Anderson Cancer Center. Prior to joining the Mischer Neuroscience Institute, Dr. Hsu was on the faculty at MD Anderson, where he served as assistant professor of neuro-oncology and the neurology residency program director. He is a charter member of the Brain Tumor Network and has volunteered for several years for Run for the Rose, serving as the medical director from 2005-07. Dr. Hsu has presented research at several national conferences, and his work has been published in numerous journals and textbooks. His most recent research has focused on novel therapies for recurrent primary CNS lymphoma, recurrent glioblastoma multiforme and intralumbar injections for cancer therapy, and he has several patents granted and pending for his treatments. Dr. Hsu’s expertise includes treatment of the following: Cancer neurology Chemotherapy neurotoxicity Leptomeningeal metastases Meningeal malignancies Recurrent glioblastoma multiforme. Dr. Hsu is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Hsu is currently accepting new patients.

Robert Regenhardt is a Neurologist practicing medicine in Houston, Texas. Dr. Regenhardt is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Stroke, Brain Aneurysm, Siderosis, Thrombectomy, and Stent Placement. Dr. Regenhardt is currently accepting new patients.